3,000,000 SHARES ALEXION PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT November 15, 2006Underwriting Agreement • November 17th, 2006 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 17th, 2006 Company Industry JurisdictionAlexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,000,000 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 450,000 additional shares (the “Optional Shares”) of its Common Stock, par value $0.0001. The shares of Common Stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.” The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are collectively called the Shares.
2,500,000 Shares ALEXION PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 15th, 2005 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 15th, 2005 Company Industry JurisdictionAlexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Morgan Stanley & Co. Incorporated (“Morgan Stanley” or the “Underwriter”) 2,500,000 shares of its Common Stock, par value $0.0001 per share (the “Shares”). The shares of Common Stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”